Resveratrol administration, in conjunction with arsenic trioxide, has yielded benefits in neuroblastoma management, by regulating cellular viability and apoptosis, brought about by reduced levels of caspase-3 and caspase-9, as well as Bcl-2. The gene discussed is CASP3; the disease is neuroblastoma.